Onderneming Vistagen Therapeutics, Inc.
Aandelen
VTGN
US92840H4002
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,37 USD | -2,46% | -2,89% | -14,98% |
Vakgebied
Aantal werknemers: 37
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Central Nervous System Therapies
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -120,50% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -120,50% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shawn Singh
CEO | Chief Executive Officer | 61 | 01-01-00 |
Cynthia Anderson
DFI | Director of Finance/CFO | 55 | 21-08-23 |
Joshua Prince
COO | Chief Operating Officer | 54 | 01-11-21 |
Ross Baker
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-21 |
Ann Cunningham
BRD | Director/Board Member | 56 | 10-01-19 |
Mark McPartland
IRC | Investor Relations Contact | 58 | 04-10-16 |
Jessica Haskell
SEC | Corporate Secretary | - | 01-08-22 |
Human Resources Officer | - | 01-01-22 | |
Erik Berglund
LAW | General Counsel | - | 01-02-21 |
Louis Monti
PRN | Corporate Officer/Principal | - | 01-12-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jon Saxe
BRD | Director/Board Member | 88 | 01-06-00 |
Jerry Gin
BRD | Director/Board Member | 81 | 01-03-16 |
Shawn Singh
CEO | Chief Executive Officer | 61 | 01-01-00 |
Chairman | 58 | 21-07-21 | |
Ann Cunningham
BRD | Director/Board Member | 56 | 10-01-19 |
Joanne Curley
BRD | Director/Board Member | 56 | 23-04-21 |
Mary Rotunno
BRD | Director/Board Member | 64 | 06-07-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 27 029 731 | 26 971 854 ( 99,79 %) | 4 522 ( 0,0167 %) | 99,79 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,98% | 118 mln. | |
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |
- Beurs
- Aandelen
- Koers VTGN
- Onderneming Vistagen Therapeutics, Inc.